Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Acute Myeloid Leukemia (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05010122
What this trial is testing

ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 42
Large-scale testing (Phase 3)Ended earlyNCT02785900
What this trial is testing

Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Seagen Inc. 240
Testing effectiveness (Phase 2)Ended earlyNCT02440568
What this trial is testing

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

Who this might be right for
Acute Myeloid Leukemia
University of Illinois at Chicago 22
Testing effectiveness (Phase 2)Study completedNCT01829503
What this trial is testing

Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Annie Im, M.D. 44
Testing effectiveness (Phase 2)Looking for participantsNCT06672146
What this trial is testing

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 93
Large-scale testing (Phase 3)Study completedNCT00179829
What this trial is testing

WT1 for the Detection of Minimal Residual Disease

Who this might be right for
LeukemiaCancer
Ann & Robert H Lurie Children's Hospital of Chicago 50
Early research (Phase 1)Study completedNCT01154439
What this trial is testing

Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 11
Testing effectiveness (Phase 2)Study completedNCT00850382
What this trial is testing

Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 89
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)WithdrawnNCT01843179
What this trial is testing

Sulindac for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT02668653
What this trial is testing

Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo 539
Not applicableUnknownNCT02192619
What this trial is testing

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Who this might be right for
Newly-diagnosed APL (de Novo or Therapy-related)Relapsed APL
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 500
Not applicableLooking for participantsNCT06458244
What this trial is testing

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Who this might be right for
Acute Myeloid Leukemia
Ruijin Hospital 90
Early research (Phase 1)Study completedNCT00990054
What this trial is testing

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Genzyme, a Sanofi Company 36
Early research (Phase 1)Active Not RecruitingNCT06034470
What this trial is testing

Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms

Who this might be right for
Acute Myeloid LeukemiaMixed Phenotype Acute LeukemiaMyelodysplastic Syndrome+2 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00274807
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Study completedNCT00357032
What this trial is testing

PXD101 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429098
What this trial is testing

Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Ended earlyNCT00723203
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT07548710
What this trial is testing

Study of SA+X in the Treatment of Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
Ruijin Hospital 205
Next Page